drugset / Trial / NCT00001442

A Pilot Study of Paclitaxel With Radiation Therapy for Locally Advanced Head and Neck Cancer

NCT00001442 ↗

Phase 1 Completed 35 enrolled National Cancer Institute (NCI)
Treatment

Summary

Radiotherapy plus Single-Agent Chemotherapy/Radiosensitization. Irradiation of tumor and involved nodes using 4-6 MV photons (brachytherapy allowed to boost primary tumor; electrons allowed to boost posterior neck and massive adenopathy); plus Paclitaxel (Bristol-Myers), Taxol, TAX, NSC-125973.

Timeline

Start
1995-07
Primary completion
—
Completion
2004-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Paclitaxel Small molecule 120 mg/m2 Intravenous